a public good project by the
Synthesis
Company
of California

© 2026

Robert Hunt | doi.page

0 works0 citations0 h-index

Robert Hunt

Publications by Year

Research Areas

Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, History and Developments in Astronomy, Pneumonia and Respiratory Infections, Spectroscopy and Laser Applications

Most-Cited Works

→ Treatment of Highly Drug-Resistant Pulmonary Tuberculosis(2020)985 cited
→ Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis(2022)528 cited
→ Pathology of Inhalation Anthrax in Cynomolgus Monkeys (Macaca fascicularis)(2003)141 cited
→ Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients(2015)92 cited
→ Severe Tuberculosis Induces Unbalanced Up‐Regulation of Gene Networks and Overexpression ofIL‐22, MIP‐1α, CCL27, IP‐10, CCR4, CCR5, CXCR3, PD1, PDL2, IL‐3, IFN‐β, TIM1,andTLR2but Low Antigen‐Specific Cellular Responses(2008)90 cited
→ Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial(2023)84 cited

→ Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness(1990)

67 cited

→ A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB(2021)62 cited

→ The behavior of solutions of ordinary, self-adjoint differential equations of arbitrary even order(1962)53 cited

→ Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial(2024)50 cited